186 related articles for article (PubMed ID: 20469965)
1. A high-content RNAi-screening assay to identify modulators of cholesterol accumulation in Niemann-Pick type C cells.
Arora S; Beaudry C; Bisanz KM; Sima C; Kiefer JA; Azorsa DO
Assay Drug Dev Technol; 2010 Jun; 8(3):295-320. PubMed ID: 20469965
[TBL] [Abstract][Full Text] [Related]
2. Endocytosis of beta-cyclodextrins is responsible for cholesterol reduction in Niemann-Pick type C mutant cells.
Rosenbaum AI; Zhang G; Warren JD; Maxfield FR
Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5477-82. PubMed ID: 20212119
[TBL] [Abstract][Full Text] [Related]
3. Laboratory diagnosis of Niemann-Pick disease type C: the filipin staining test.
Vanier MT; Latour P
Methods Cell Biol; 2015; 126():357-75. PubMed ID: 25665455
[TBL] [Abstract][Full Text] [Related]
4. FTY720/fingolimod increases NPC1 and NPC2 expression and reduces cholesterol and sphingolipid accumulation in Niemann-Pick type C mutant fibroblasts.
Newton J; Hait NC; Maceyka M; Colaco A; Maczis M; Wassif CA; Cougnoux A; Porter FD; Milstien S; Platt N; Platt FM; Spiegel S
FASEB J; 2017 Apr; 31(4):1719-1730. PubMed ID: 28082351
[TBL] [Abstract][Full Text] [Related]
5. Visualization of cholesterol deposits in lysosomes of Niemann-Pick type C fibroblasts using recombinant perfringolysin O.
Kwiatkowska K; Marszałek-Sadowska E; Traczyk G; Koprowski P; Musielak M; Lugowska A; Kulma M; Grzelczyk A; Sobota A
Orphanet J Rare Dis; 2014 Apr; 9():64. PubMed ID: 24775609
[TBL] [Abstract][Full Text] [Related]
6. The proteasome inhibitor bortezomib reduced cholesterol accumulation in fibroblasts from Niemann-Pick type C patients carrying missense mutations.
Macías-Vidal J; Girós M; Guerrero M; Gascón P; Serratosa J; Bachs O; Coll MJ
FEBS J; 2014 Oct; 281(19):4450-66. PubMed ID: 25131710
[TBL] [Abstract][Full Text] [Related]
7. Niemann-Pick Disease Type C: from molecule to clinic.
Tang Y; Li H; Liu JP
Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):132-40. PubMed ID: 19566836
[TBL] [Abstract][Full Text] [Related]
8. Clues to neuro-degeneration in Niemann-Pick type C disease from global gene expression profiling.
Reddy JV; Ganley IG; Pfeffer SR
PLoS One; 2006 Dec; 1(1):e19. PubMed ID: 17183645
[TBL] [Abstract][Full Text] [Related]
9. A human iPSC-derived inducible neuronal model of Niemann-Pick disease, type C1.
Prabhu AV; Kang I; De Pace R; Wassif CA; Fujiwara H; Kell P; Jiang X; Ory DS; Bonifacino JS; Ward ME; Porter FD
BMC Biol; 2021 Oct; 19(1):218. PubMed ID: 34592985
[TBL] [Abstract][Full Text] [Related]
10. Primary cilium alterations and expression changes of Patched1 proteins in niemann-pick type C disease.
Formichi P; Battisti C; De Santi MM; Guazzo R; Tripodi SA; Radi E; Rossi B; Tarquini E; Federico A
J Cell Physiol; 2018 Jan; 233(1):663-672. PubMed ID: 28332184
[TBL] [Abstract][Full Text] [Related]
11. High-content screen for modifiers of Niemann-Pick type C disease in patient cells.
Pugach EK; Feltes M; Kaufman RJ; Ory DS; Bang AG
Hum Mol Genet; 2018 Jun; 27(12):2101-2112. PubMed ID: 29659804
[TBL] [Abstract][Full Text] [Related]
12. Alterations in Cholesterol and Phosphoinositides Levels in the Intracellular Cholesterol Trafficking Disorder NPC.
Cologna SM; Pathmasiri KC; Pergande MR; Rosenhouse-Dantsker A
Adv Exp Med Biol; 2023; 1422():143-165. PubMed ID: 36988880
[TBL] [Abstract][Full Text] [Related]
13. Niemann-Pick Type C disease: characterizing lipid levels in patients with variant lysosomal cholesterol storage.
Tängemo C; Weber D; Theiss S; Mengel E; Runz H
J Lipid Res; 2011 Apr; 52(4):813-25. PubMed ID: 21245028
[TBL] [Abstract][Full Text] [Related]
14. Identification of mutation in NPC2 by exome sequencing results in diagnosis of Niemann-Pick disease type C.
Alavi A; Nafissi S; Shamshiri H; Nejad MM; Elahi E
Mol Genet Metab; 2013; 110(1-2):139-44. PubMed ID: 23791309
[TBL] [Abstract][Full Text] [Related]
15. Niemann-Pick type C disease: importance of N-glycosylation sites for function and cellular location of the NPC2 protein.
Chikh K; Vey S; Simonot C; Vanier MT; Millat G
Mol Genet Metab; 2004 Nov; 83(3):220-30. PubMed ID: 15542393
[TBL] [Abstract][Full Text] [Related]
16. Chemical screen to reduce sterol accumulation in Niemann-Pick C disease cells identifies novel lysosomal acid lipase inhibitors.
Rosenbaum AI; Rujoi M; Huang AY; Du H; Grabowski GA; Maxfield FR
Biochim Biophys Acta; 2009 Dec; 1791(12):1155-65. PubMed ID: 19699313
[TBL] [Abstract][Full Text] [Related]
17. Acid ceramidase improves mitochondrial function and oxidative stress in Niemann-Pick type C disease by repressing STARD1 expression and mitochondrial cholesterol accumulation.
Torres S; Solsona-Vilarrasa E; Nuñez S; Matías N; Insausti-Urkia N; Castro F; Casasempere M; Fabriás G; Casas J; Enrich C; Fernández-Checa JC; Garcia-Ruiz C
Redox Biol; 2021 Sep; 45():102052. PubMed ID: 34175669
[TBL] [Abstract][Full Text] [Related]
18. Quantitative comparison of the efficacy of various compounds in lowering intracellular cholesterol levels in Niemann-Pick type C fibroblasts.
Wehrmann ZT; Hulett TW; Huegel KL; Vaughan KT; Wiest O; Helquist P; Goodson H
PLoS One; 2012; 7(10):e48561. PubMed ID: 23144769
[TBL] [Abstract][Full Text] [Related]
19. Gpnmb Is a Potential Marker for the Visceral Pathology in Niemann-Pick Type C Disease.
Marques AR; Gabriel TL; Aten J; van Roomen CP; Ottenhoff R; Claessen N; Alfonso P; Irún P; Giraldo P; Aerts JM; van Eijk M
PLoS One; 2016; 11(1):e0147208. PubMed ID: 26771826
[TBL] [Abstract][Full Text] [Related]
20. A human neuronal model of Niemann Pick C disease developed from stem cells isolated from patient's skin.
Bergamin N; Dardis A; Beltrami A; Cesselli D; Rigo S; Zampieri S; Domenis R; Bembi B; Beltrami CA
Orphanet J Rare Dis; 2013 Feb; 8():34. PubMed ID: 23433359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
